Shaping the future from the small scale: dry powder inhalation of CRISPR-Cas9 lipid nanoparticles for the treatment of lung diseases-Reference-Cited by-同舟云学术

Shaping the future from the small scale: dry powder inhalation of CRISPR-Cas9 lipid nanoparticles for the treatment of lung diseases

Published:2023-03-12 Issue:4 Volume:20 Page:471-487
ISSN:1742-5247
Container-title:Expert Opinion on Drug Delivery
language:en
Short-container-title:Expert Opinion on Drug Delivery

Author:

Carneiro Simone P.¹,Greco Antonietta²³^ORCID,Chiesa Enrica³,Genta Ida³^ORCID,Merkel Olivia M.¹^ORCID

Affiliation:

1. Department of Pharmacy, Pharmaceutical Technology and Biopharmaceutics, Ludwig-Maximilians-University of Munich, Munich, Germany

2. University School for Advanced Studies (IUSS), Pavia, Italy

3. Department of Drug Sciences, University of Pavia, Pavia, Italy

Funder

the Alexander von Humboldt Foundation in the form of a Humboldt Postdoctoral Research

Publisher

Informa UK Limited

Subject

Pharmaceutical Science

Link

https://www.tandfonline.com/doi/pdf/10.1080/17425247.2023.2185220

Reference163 articles.

1. who.int [Internet]. Chronic obstructive pulmonary disease (COPD). [cited 2022 May 20]. Available from: https://www.who.int/news-room/fact-sheets/detail/chronic-obstructive-pulmonary-disease-(copd)).

2. who.int [Internet]. Cancer. [cited 2022 Feb 3]. Available from:https://www.who.int/news-room/fact-sheets/detail/cancer

3. who.int [Internet]. Asthma. [cited 2022 May 11]. Available from: https://www.who.int/news-room/fact-sheets/detail/asthma

4. A new era for people with cystic fibrosis

5. Cystic Fibrosis Lung Disease: An Overview

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Overcoming barriers in cystic fibrosis therapy through inhalational lipid nanoparticles: Challenges and advances;Journal of Drug Delivery Science and Technology;2023-11

2. Rapid-mixing production of lipid nanoparticles for biomolecules delivery;2023-10-29

3. Biomaterials-mediated CRISPR/Cas9 delivery: recent challenges and opportunities in gene therapy;Frontiers in Chemistry;2023-09-28

4. CRISPR/Cas9 Genome Editing for Tissue‐Specific In Vivo Targeting: Nanomaterials and Translational Perspective;Advanced Science;2023-05-11